Stockreport

Novartis to Acquire Synnovation Therapeutics' Pan-Mutant Selective PI3Ka Inhibitor Program [Yahoo! Finance]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF WILMINGTON, Del., March 20, 2026 BUSINESS WIRE )--Synnovation Therapeutics, LLC ("Synnovation"), a clinical-stage biotechnology company with a diverse pipeline of novel [Read more]